Brachytherapy seeds work on prostate cancer:
This article was originally published in Clinica
Executive Summary
Brachytherapy using Theragenics' radioactive seed implants performed as well as or better than traditional treatments for prostate cancer such as radical prostatectomy and external beam radiation, according to a nine-year US study. Some 83.5% of the 230 stage I and II patients treated with the company's TheraSeed - palladium 103 - implants were cancer-free at nine years, researchers from the Seattle Prostate Institute in Washington reported in the March issue of the International Journal of Radiation Oncology, Biology and Physics. Only 3% of patients experienced prostate cancer recurrence, said Theragenics of Buford, Georgia.